Kandzari, D. E., Tcheng, J. E., Grines, C. L., Cohen, D. J., Bakhai, A., Cox, D. A., … Stone, G. W. (2003). Safety of an early discharge strategy following primary intervention with adjunctive glycoprotein IIb/IIIa inhibition: The CADILLAC trial. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (Vol. 41, pp. 538A-539A). CHICAGO, ILLINOIS: ELSEVIER SCIENCE INC.

Kandzari, D. E., J. E. Tcheng, C. L. Grines, D. J. Cohen, A. Bakhai, D. A. Cox, T. D. Stuckey, et al. “Safety of an early discharge strategy following primary intervention with adjunctive glycoprotein IIb/IIIa inhibition: The CADILLAC trial.” In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 41:538A-539A. ELSEVIER SCIENCE INC, 2003.

Kandzari DE, Tcheng JE, Grines CL, Cohen DJ, Bakhai A, Cox DA, et al. Safety of an early discharge strategy following primary intervention with adjunctive glycoprotein IIb/IIIa inhibition: The CADILLAC trial. In: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. ELSEVIER SCIENCE INC; 2003. p. 538A-539A.

Kandzari, D. E., et al. “Safety of an early discharge strategy following primary intervention with adjunctive glycoprotein IIb/IIIa inhibition: The CADILLAC trial.” JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, vol. 41, no. 6, ELSEVIER SCIENCE INC, 2003, pp. 538A-539A.

Kandzari DE, Tcheng JE, Grines CL, Cohen DJ, Bakhai A, Cox DA, Stuckey TD, Effron M, Griffin JJ, Turco M, Carroll JD, Fahy M, Mehran R, Stone GW. Safety of an early discharge strategy following primary intervention with adjunctive glycoprotein IIb/IIIa inhibition: The CADILLAC trial. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. ELSEVIER SCIENCE INC; 2003. p. 538A-539A.